These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 39452

  • 1. Treatment of Parkinson's disease with dopamine agonists: a review.
    Lieberman A, Neophytides A, Kupersmith M, Casson I, Durso R, Foo SH, Khayali M, Tartaro T, Goldstein M.
    Am J Med Sci; 1979; 278(1):65-76. PubMed ID: 39452
    [Abstract] [Full Text] [Related]

  • 2. Lergotrile in Parkinson disease: further studies.
    Lieberman AN, Gopinathan G, Estey E, Kupersmith M, Goodgold A, Goldstein M.
    Neurology; 1979 Feb; 29(2):267-72. PubMed ID: 34808
    [Abstract] [Full Text] [Related]

  • 3. Comparison between lergotrile and bromocriptine in parkinsonism.
    Teychenne PF, Pfeiffer RF, Bern SM, McInturff D, Calne DB.
    Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273
    [Abstract] [Full Text] [Related]

  • 4. Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.
    Jellinger K.
    J Neurol; 1982 Apr; 227(2):75-88. PubMed ID: 6180142
    [Abstract] [Full Text] [Related]

  • 5. Treatment of Parkinson's disease with lergotrile mesylate.
    Lieberman A, Estey E, Kupersmith M, Gopinathan G, Goldstein M.
    JAMA; 1977 Nov 28; 238(22):2380-2. PubMed ID: 335094
    [Abstract] [Full Text] [Related]

  • 6. Bromocriptine in Parkinson disease: further studies.
    Lieberman AN, Kupersmith M, Gopinathan G, Estey E, Goodgold A, Goldstein M.
    Neurology; 1979 Mar 28; 29(3):363-9. PubMed ID: 571981
    [Abstract] [Full Text] [Related]

  • 7. Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.
    Teychenne PF, Rosin AJ, Plotkin CN, Calne DB.
    Br J Clin Pharmacol; 1980 Jan 28; 9(1):47-50. PubMed ID: 6101955
    [Abstract] [Full Text] [Related]

  • 8. Treatment of parkinson's disease with bromocriptine.
    Lieberman A, Kupersmith M, Estey E, Goldstein M.
    N Engl J Med; 1976 Dec 16; 295(25):1400-4. PubMed ID: 989885
    [Abstract] [Full Text] [Related]

  • 9. Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085.
    Schneider E, Hubener K, Fischer PA.
    Neurology; 1983 Apr 16; 33(4):468-72. PubMed ID: 6682193
    [Abstract] [Full Text] [Related]

  • 10. Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
    Lieberman AN, Neophytides A, Leibowitz M, Gopinathan G, Pact V, Walker R, Goodgold A, Goldstein M.
    Adv Neurol; 1983 Apr 16; 37():95-108. PubMed ID: 6858782
    [Abstract] [Full Text] [Related]

  • 11. Long-term use of dopamine agonists in Parkinson's disease.
    Jankovic J.
    Clin Neuropharmacol; 1985 Apr 16; 8(2):131-40. PubMed ID: 3891082
    [No Abstract] [Full Text] [Related]

  • 12. Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.
    Marsden CD.
    Drugs; 1998 Apr 16; 55 Suppl 1():17-22. PubMed ID: 9483166
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
    Godwin-Austen RB, Smith NJ.
    J Neurol Neurosurg Psychiatry; 1977 May 16; 40(5):479-82. PubMed ID: 330825
    [Abstract] [Full Text] [Related]

  • 14. Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients.
    Serby M, Angrist B, Lieberman A.
    Adv Biochem Psychopharmacol; 1980 May 16; 23():287-92. PubMed ID: 6104908
    [No Abstract] [Full Text] [Related]

  • 15. Bromocriptine combined with levodopa in Parkinson's disease.
    Gauthier G, Martins da Silva A.
    Eur Neurol; 1982 May 16; 21(4):217-26. PubMed ID: 7117308
    [Abstract] [Full Text] [Related]

  • 16. Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease.
    Serby M, Angrist B, Lieberman A.
    Am J Psychiatry; 1978 Oct 16; 135(10):1227-9. PubMed ID: 29497
    [No Abstract] [Full Text] [Related]

  • 17. D-1 and D-2 agonists in Parkinson's disease.
    Lieberman AN, Goldstein M, Gopinathan G, Neophytides A.
    Can J Neurol Sci; 1987 Aug 16; 14(3 Suppl):466-73. PubMed ID: 2960431
    [Abstract] [Full Text] [Related]

  • 18. Bromocriptine in Parkinson disease.
    Lieberman AN, Goldstein M.
    Pharmacol Rev; 1985 Jun 16; 37(2):217-27. PubMed ID: 3901046
    [Abstract] [Full Text] [Related]

  • 19. Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
    Parkes JD, Debono AG, Marsden CD.
    J Neurol Neurosurg Psychiatry; 1976 Nov 16; 39(11):1101-8. PubMed ID: 1036999
    [Abstract] [Full Text] [Related]

  • 20. Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
    Kartzinel R, Shoulson I, Calne DB.
    Neurology; 1976 Jun 16; 26(6 PT 1):511-3. PubMed ID: 778655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.